research Long-COVID and General Health Status in Hospitalized COVID-19 Survivors
Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.
Search
for
Sort by
Research
90-120 / 1000+ results 
research Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Skin Manifestations
Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.
research Skin Tissue: A Place for SARS-CoV-2 to Multiply and Transmit?
SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.
research Assurance Versus Frustration: A Retrospective Single-Center Analysis of Female Patients with Acute Telogen Effluvium
Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.
research 58-Year-Old Female with Diffuse Thinning of the Hair
Stress can cause temporary hair loss, which usually gets better after the stress is gone.
research 55-Year-Old Female with Alopecia of the Scalp and Body After Chemotherapy
Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.
research Trichoscopy as a Diagnostic Method in Non-Scarring Alopecia
Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.
research Telogen Effluvium: A Sequela of COVID-19
COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.
research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation
COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.
research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium
COVID-19 infection can significantly cause temporary hair loss.
research Case Report: Hair Care Routine to Treat Telogen Effluvium Associated With Post-COVID-19 Infection
A woman's COVID-19 related hair loss improved after using a specific hair care routine for 30 days.
research Telogen Effluvium Associated with COVID-19 Infection
COVID-19 may cause hair loss due to infection stress or treatments.
research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management
COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.
research Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients
COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.
research A Surge in the Incidence of Telogen Effluvium in Minority Predominant Communities Heavily Impacted by COVID-19
More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.
research Prevalence of Telogen Effluvium Hair Loss in COVID-19 Patients and Its Relationship with Disease Severity
COVID-19 patients may experience hair loss, but it's not linked to their age or sex.
research Telogen Effluvium, Beau's Lines, and Acral Peeling Associated with COVID-19 Infection
A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.
research Race, Ethnicity, and Comorbidities Are Critical Factors in the Diagnosis of Telogen Effluvium During the COVID-19 Pandemic
Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.
research A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis After the Administration of a Heterologous COVID-19 Vaccine Scheme
Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.
research Telogen Effluvium Caused by COVID-19 in Elmhurst, New York: Report of a Cohort and Review
COVID-19 has increased hair loss, but many patients see regrowth within months.
research Investigating Biochemical Biomarkers in Telogen Effluvium Post-COVID-19 Patients: A Retrospective Cohort Study
COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.
research Impact of the COVID-19 Pandemic on Telogen Effluvium: A Nationwide Multicentre Interrupted Time Series Study
COVID-19 increased hair loss cases, but vaccination did not.
research Global Epidemiology of Telogen Effluvium After COVID-19 Pandemic: A Systematic Review and Modeling Study
Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.
research Evaluation of the Relationship Between Favipiravir Use and Telogen Effluvium in COVID-19 Patients
Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.
research Telogen Effluvium and Trichodynia in Different Severity Groups of Post COVID-19 Patients
Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.
research Telogen Effluvium After COVID-19 Infection: A Case Report
COVID-19 infection may cause hair loss a few months after recovery.
research Reporting Cases of Telogen Effluvium as a Sequelae of COVID-19 Infection
COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.
research COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium: The Role of Proteoglycan Replacement Therapy with Nourkrin in Clinical Treatment of COVID-19 Associated Hair Loss
COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.
research COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium: The Role of Proteoglycan Replacement Therapy with Nourkrin in Clinical Treatment of COVID-19 Associated Hair Loss
COVID-19 may increase hair loss, and Nourkrin® could help treat it.
research Telogen Effluvium: Long-Term COVID-19 Symptom
COVID-19 recovery can lead to temporary hair loss called telogen effluvium.